| Not Yet Recruiting | A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults Chronic Liver Disease (CLD) | Phase 1 | 2026-05-01 |
| Not Yet Recruiting | A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects Chronic Heart Failure | Phase 1 | 2026-04-01 |
| Not Yet Recruiting | A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults Gastritis | Phase 1 | 2026-04-01 |
| Recruiting | A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects Benign Prostatic Hyperplasia | Phase 1 | 2026-02-26 |
| Enrolling By Invitation | A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of AD-117 in Mixed Dyslipidemia, Food Effect Study of AD-117 | Phase 1 | 2026-02-01 |
| Not Yet Recruiting | Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322 Hypertension | Phase 1 | 2026-01-27 |
| Recruiting | Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151' Gastric Ulcer | Phase 1 | 2026-01-27 |
| Not Yet Recruiting | A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C Hypertension, Hyperlipidemia | Phase 1 | 2026-01-23 |
| Not Yet Recruiting | A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adul Benign Prostatic Hyperplasia | Phase 1 | 2025-12-01 |
| Not Yet Recruiting | A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A Mixed Dyslipidemia | Phase 1 | 2025-12-01 |
| Completed | A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD- Primary Hypercholesterolaemia | Phase 1 | 2025-07-12 |
| Completed | A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A a Primary Hypertension | Phase 1 | 2025-07-12 |
| Not Yet Recruiting | The Food Effect on PK Characteristics and Safety Profiles of PA-111 Mixed Dyslipidemia | Phase 1 | 2025-05-01 |
| Not Yet Recruiting | A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A Gastroesophageal Reflux Disease (GERD) | Phase 1 | 2025-04-21 |
| Recruiting | A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A Mixed Dyslipidemia | Phase 1 | 2025-04-01 |
| Completed | The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151 Gastric Ulcer | Phase 1 | 2025-03-21 |
| Recruiting | A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284 Primary Hypercholesterolaemia | Phase 1 | 2025-03-10 |
| Not Yet Recruiting | A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282 Primary Hypercholesterolemia | Phase 3 | 2025-02-01 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B Essential Hypertension | Phase 3 | 2024-07-31 |
| Recruiting | Phase III Study to Evaluate the Efficacy and Safety of AD-209 Hypertension,Essential | Phase 3 | 2024-05-20 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of AD-224 Hypertension,Essential | Phase 3 | 2024-04-15 |
| Completed | A Study to Evaluate the Efficacy and Safety of AD-223 Hypertension,Essential | Phase 3 | 2024-02-15 |
| Completed | A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121 Gastro Esophageal Reflux | Phase 1 | 2023-09-15 |
| Completed | A Study to Evaluate the Efficacy and Safety of AD-209 Hypertension, Essential | Phase 2 | 2023-04-05 |
| Completed | A Study to Assess the Safety and Pharmacokinetics of AD-104-A Hyperlipidemias | Phase 1 | 2023-03-13 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of AD-218 Mixed Dyslipidemia | Phase 3 | 2022-07-27 |
| Completed | A Study to Evaluate the Safety and Pharmacokinetics of AD-221 Compared to Coadministration of AD-221A and AD-2 Hyperlipidemias | Phase 1 | 2022-01-05 |
| Completed | A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A Primary Hypercholesterolemia | Phase 3 | 2021-11-16 |
| Completed | A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091 Embolism and Thrombosis | Phase 1 | 2021-11-09 |
| Completed | A Study to Compare PK, PD and Safety of the AD-214 and AD-2141 Gastroesophageal Reflux Disease | Phase 1 | 2021-11-01 |
| Completed | A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131 Gastroesophagus Reflux Disease | Phase 1 | 2021-10-15 |
| Completed | A Study to Evaluate the Efficacy and Safety of AD-208 Androgenetic Alopecia | Phase 3 | 2021-06-09 |
| Completed | A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132 Gastroesophagus Reflux Disease | Phase 1 | 2021-03-21 |
| Completed | A Study to Compare PK, PD and Safety of the AD-214-02 and Rabeprazole Gastroesophageal Reflux Disease | Phase 1 | 2020-12-05 |
| Completed | Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102 Hypertension | Phase 1 | 2020-11-16 |
| Completed | Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022 Hypertension, Essential, Primary Hypercholesterolemia | Phase 3 | 2020-10-22 |
| Completed | A Study to Compare PK, PD and Safety of the AD-214 10/600mg and Rabeprazole Gastroesophageal Reflux Disease | Phase 1 | 2020-08-28 |
| Completed | Evaluating the Pharmacokinetic Interactions and Safety Between AD-2111 and AD-2112 Pain | Phase 1 | 2020-05-30 |
| Completed | Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension Hypertension,Essential | Phase 2 | 2020-02-25 |
| Completed | Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine Hypercholesterolemia, Hypertension | Phase 3 | 2020-01-23 |
| Completed | To Evaluate the Pharmacokinetics and Safety of AD-208 Androgenetic Alopecia | Phase 1 | 2020-01-03 |
| Completed | A Study to Evaluate the Efficacy and Safety of AD-203 Acute Gastritis, Chronic Gastritis | Phase 3 | 2019-09-23 |
| Completed | A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole Gastritis | Phase 1 | 2019-06-05 |
| Completed | Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy Volunteers Osteoporosis | Phase 1 | 2019-02-28 |
| Completed | Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan Hypercholesterolemia, Hypertension | Phase 3 | 2019-02-26 |
| Completed | Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy Volunteers Osteoporosis | Phase 1 | 2018-12-14 |
| Completed | Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072 Hyperlipidemias, Hypertension | Phase 1 | 2018-09-28 |
| Completed | Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012 Hyperlipidemias, Hypertension | Phase 1 | 2018-06-12 |